Showing results (1-10 of 316) with videos related to
Sort By:
Pageof 32
The Medical Journal of Australia|February 27, 2004
Patient education and self-management programs in arthritisRichard H Osborne, Jean M Spinks, Ian P WicksSeminars in Arthritis and Rheumatism|August 20, 2013
Improving treatment with methotrexate in rheumatoid arthritis-development of a multimedia patient education program and the MiRAK, a new instrument to evaluate methotrexate-related knowledgeSabina Ciciriello, Rachelle Buchbinder, Richard H Osborne, et al.The Journal of Rheumatology|November 7, 2007
Prevalence and cost of musculoskeletal disorders: a population-based, public hospital system healthcare consumption approachRichard H Osborne, Mandana Nikpour, Lucy Busija, et al.Arthritis and Rheumatism|October 7, 2005
Severely compromised quality of life in women and those of lower socioeconomic status waiting for joint replacement surgeryIlana N Ackerman, Stephen E Graves, Ian P Wicks, et al.Nature Reviews. Rheumatology|December 4, 2015
Targeting GM-CSF in inflammatory diseasesIan P Wicks, Andrew W RobertsNature Reviews. Rheumatology|July 10, 2020
Cell death in chronic inflammation: breaking the cycle to treat rheumatic diseaseHolly Anderton, Ian P Wicks, John SilkeCurrent Pharmaceutical Design|March 12, 2015
Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedsideXiao Liu, Andrew J Teichtahl, Ian P WicksTrends in Molecular Medicine|July 11, 2020
Inflammasomes and Cell Death: Common Pathways in Microparticle DiseasesMaryam Rashidi, Ian P Wicks, James E VinceAustralian Health Review : a Publication of the Australian Hospital Association|August 30, 2011
Paying the right price for pharmaceuticals: a case study of why the comparator mattersJean M Spinks, Jeff R J RichardsonImmunology and Cell Biology|September 13, 2003
Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritisIan K Campbell, Lynden J Roberts, Ian P WicksPageof 32